The Report Guru

The weight loss and weight management market is expected to reach USD 245.51 billion by 2022 from USD 175.94 billion in 2017, at a CAGR of 6.9%. Key Players in the Weight Loss and Weight Management Market Focus on New Product Launches and Agreements, Partnerships, and Collaborations as their Key Growth Strategies Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1152 Prominent players in the weight loss and weight management market, by diet, include Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), NutriSystem Ltd. (U.S.), and Kellogg Company (U.S.). Ethicon, Inc. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), and Olympus Corporation (Japan) are some of the prominent players in the equipment market, while Brunswick Corporation (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), and Technogym SpA (Italy) are the leading players in the fitness equipment segment. The prominent

The weight loss and weight management market is expected to reach USD 245.51 billion by 2022 from USD 175.94 billion in 2017, at a CAGR of 6.9%. Key Players in the Weight Loss and Weight Management Market Focus on New Product Launches and Agreements, Partnerships, and Collaborations as their Key Growth Strategies Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1152 Prominent players in the weight loss and weight management market, by diet, include Atkins Nutritionals, Inc. (U.S.), Herbalife Ltd. (U.S.), NutriSystem Ltd. (U.S.), and Kellogg Company (U.S.). Ethicon, Inc. (U.S.), Covidien plc (U.S.), Apollo Endosurgery (U.S.), and Olympus Corporation (Japan) are some of the prominent players in the equipment market, while Brunswick Corporation (U.S.), Amer Sports (Finland), Johnson Health Technology, Ltd. (Taiwan), Cybex International (U.S.), and Technogym SpA (Italy) are the leading players in the fitness equipment segment. The prominent

According to research report Cardiac Monitoring Devices Market is expected to reach USD 30.56 billion by 2027 from USD 22.12 billion in 2019, at a CAGR of 4.0% during the forecast period. Factors such as the increasing incidence of cardiovascular diseases and technological advancements in devices are expected to propel the growth of the market. However, price sensitivity and limited reimbursements for remote cardiac monitoring devices are expected to restrain the growth of the CM & CRM devices market. Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=55 The hospitals segment accounted for the largest share of the cardiac monitoring and cardiac rhythm management devices market By end user, the cardiac monitoring and cardiac rhythm management devices market is classified into hospitals, home & ambulatory care settings, and other end users. The hospitals segment accounted for the largest share of the market. The large share of this segme

According to research report Preclinical Imaging Market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016 to 2021. The Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Over the last two decades, preclinical imaging has witnessed significant importance in the drug discovery and development. Development of technologically advanced multi-modality preclinical imaging systems and their increased adoption in preclinical research studies acted as driving factor for global preclinical imaging market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=841 Leading Market Players - The key players in the preclinical imaging market focus on various strategies such as product approvals, launches, and enhancements; geographic expansions; partnerships, agreements, and collaborations; and strategic a

According to the new market research report Single-use Bioreactors Market is expected to grow at a CAGR of 21.9% from 2017 to 2022, to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017. In the current market scenario, there is a growing demand for single-use bioreactor products. The major factors driving the growth of the Single Use Bioreactors include the increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in cultivating marine organisms, and reduced impact on the environment. Download Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750 Thermo Fisher Scientific, Inc (U.S.) Held the Leadership Position in the SUB in 2014 Owing to Its Broad Product Portfolio and Strong Brand Name The Single Use Bioreactors Market is highly consolidated, with the top five players accounting for a share of more than 75%. The major players include Thermo Fischer Scientific, Inc. (U.S.), Sartorius AG (Germany

According to the research report the coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. Prominent players in the coronary stent market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany). Download Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=77411272 Other players in the market include companies such as OrbusNeich (Hong Kong), Aachen Resonance GmbH (Germany), amg International GmbH (Germany), Arterial Remodeling Technologies (France), Bioabsorbable Therapeutics, Inc. (U.S.), Devax, Inc. (U.S.), Elixir Medical Corpora

According to research report the global Depth of Anesthesia Monitoring Market is projected to reach USD 170 million by 2024, at a CAGR of 3.2% during the forecast period. The growing patient pool in hospitals and the increasing number of surgeries in the US are the major factors contributing to the growth of this market. However, depth of anesthesia monitoring devices is expensive and have considerably high installation and maintenance costs. Owing to this, their adoption is limited in small outpatient settings and clinics. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243124200 Based on the mode of purchase, the GPOs segment accounted for the largest share of the market in 2018. This can be attributed to the superior bargaining power of GPOs in bulk purchases over individual clinical settings. However, the direct purchase segment is expected to witness higher growth during the forecast period. Based on device type, modules accounted for the

According to a new market research report Operating Room Integration Market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019. Factors such as the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs are driving the growth of the operating room integration market during the forecast period.   Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160774667 The software segment accounted for the largest share of the operating room integration market, by component, in 2018 The software segment accounted for the largest share of the operating room integration market in 2018. OR integration software helps streamline surgical workflows by enabling seamless communication between different systems as well as ensuring the effective and easier

Competent cells are E.coli cells that possess altered cell walls which enable the assimilation of foreign DNA. These cells are widely used in cloning and protein expressions applications. Advancements in molecular cloning research due to the emergence of new technologies and increasing commercial demand for molecular cloned products and recombinant proteins are the major factors driving the growth of the competent cells market. According to research report the global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Download PDF Brochure: https://www.marketsandmarkets.com/requestsampleNew.asp?id=265815900 • By type, the chemically competent cells segment is expected to dominate the market in 2017 • By application, the cloning segment is expected to dominate the market in 2017 • By end user, the academic research institutes segment is expected to dominate the market in 2017 • North America to dominate the c

According to the new market research Blood Gas Analyzer Market is expected to reach USD 636.0 Million by 2021, at a CAGR of 4.6% during the forecast period of 2016 to 2021. A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of this market in the coming years. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 Leading players in blood gas analyzer market are focusing on the launch of new and improved products as their key growth strategy. The major players in the global blood gas analyzer market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany). The top 3 companies’ together

Factors driving the growth of this market include the increasing incidence of cardiovascular diseases and the launch of innovative and technologically advanced interventional cardiology devices. The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%. The interventional cardiology devices market is consolidated in nature due to the presence of a large number of players. The key players in the market are Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany). Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548 Most companies in the interventional cardiology devices market adopted agreements, expansions, and product launches as the key business growth strategy. These strategies accounted for the largest share of the overall growth